$node = stdClass Object (
[nid] => [22980]
[vid] => [23091]
[type] => [biblio]
[status] => [1]
[created] => [1254329253]
[changed] => [1264709800]
[comment] => [2]
[promote] => [1]
[sticky] => [0]
[revision_timestamp] => [1264709800]
[title] => [Generation of pluripotent stem cells from patients with type 1 diabetes.]
[body] => [<span class="Z3988" title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rfr_id=info%3Asid%2Fwww.diabetescenters.org&rft.genre=article&rft.atitle=Generation+of+pluripotent+stem+cells+from+patients+with+type+1+diabetes.&rft.title=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&rft.date=2009&rft.aulast=Maehr+R&rft.aufirst=Chen+Snitow+Ludwig+Yagasaki+Goland+Leibel+RL+Melton+DA&rft_id=http%3A%2F%2Fwww.pnas.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D19720998"></span><div class="biblio_type"><h3>Publication Type:</h3> Journal Article</div>
<div class="biblio_authors"><h3>Authors:</h3> <a href="/biblio/author/Maehr+R">Maehr R , Chen S , Snitow M , Ludwig T , Yagasaki L , Goland R , Leibel RL , Melton DA ,</a></div>
<div class="biblio_source"><h3>Source: </h3> Proceedings of the National Academy of Sciences of the United States of America (2009)</div>
<h3>URL:</h3><a href="http://www.pnas.org/cgi/pmidlookup?view=long&pmid=19720998">http://www.pnas.org/cgi/pmidlookup?view=long&pmid=19720998</a>
<h3>Abstract:</h3> <p>Type 1 diabetes (T1D) is the result of an autoimmune destruction of pancreatic beta cells. The cellular and molecular defects that cause the disease remain unknown. Pluripotent cells generated from patients with T1D would be useful for disease modeling. We show here that induced pluripotent stem (iPS) cells can be generated from patients with T1D by reprogramming their adult fibroblasts with three transcription factors (OCT4, SOX2, KLF4). T1D-specific iPS cells, termed DiPS cells, have the hallmarks of pluripotency and can be differentiated into insulin-producing cells. These results are a step toward using DiPS cells in T1D disease modeling, as well as for cell replacement therapy.</p>
]
[log] => []
[format] => [1]
[uid] => [1]
[name] => [admin]
[picture] => []
[data] => [a:0:{}]
[biblio_type] => [102]
[biblio_number] => []
[biblio_section] => []
[biblio_other_number] => []
[biblio_secondary_title] => [Proceedings of the National Academy of Sciences of the United States of America]
[biblio_tertiary_title] => []
[biblio_short_title] => []
[biblio_alternate_title] => []
[biblio_translated_title] => []
[biblio_authors] => [Maehr R , Chen S , Snitow M , Ludwig T , Yagasaki L , Goland R , Leibel RL , Melton DA ,]
[biblio_secondary_authors] => []
[biblio_tertiary_authors] => []
[biblio_corp_author] => []
[biblio_other_author_affiliations] => []
[biblio_edition] => []
[biblio_publisher] => []
[biblio_original_publication] => []
[biblio_reprint_edition] => []
[biblio_place_published] => []
[biblio_year] => [2009]
[biblio_volume] => []
[biblio_number_of_volumes] => []
[biblio_pages] => []
[biblio_date] => []
[biblio_isbn] => []
[biblio_issn] => []
[biblio_lang] => [eng]
[biblio_abst_e] => [<p>Type 1 diabetes (T1D) is the result of an autoimmune destruction of pancreatic beta cells. The cellular and molecular defects that cause the disease remain unknown. Pluripotent cells generated from patients with T1D would be useful for disease modeling. We show here that induced pluripotent stem (iPS) cells can be generated from patients with T1D by reprogramming their adult fibroblasts with three transcription factors (OCT4, SOX2, KLF4). T1D-specific iPS cells, termed DiPS cells, have the hallmarks of pluripotency and can be differentiated into insulin-producing cells. These results are a step toward using DiPS cells in T1D disease modeling, as well as for cell replacement therapy.</p>]
[biblio_abst_f] => []
[biblio_full_text] => [0]
[biblio_keywords] => []
[biblio_url] => [http://www.pnas.org/cgi/pmidlookup?view=long&pmid=19720998]
[biblio_doi] => []
[biblio_issue] => []
[biblio_type_of_work] => []
[biblio_accession_number] => []
[biblio_call_number] => []
[biblio_notes] => []
[biblio_coins] => [<span class="Z3988" title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rfr_id=info%3Asid%2Fwww.diabetescenters.org&rft.genre=article&rft.atitle=Generation+of+pluripotent+stem+cells+from+patients+with+type+1+diabetes.&rft.title=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&rft.date=2009&rft.aulast=Maehr+R&rft.aufirst=Chen+Snitow+Ludwig+Yagasaki+Goland+Leibel+RL+Melton+DA&rft_id=http%3A%2F%2Fwww.pnas.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D19720998"></span>]
[biblio_research_notes] => []
[biblio_custom1] => [http://www.ncbi.nlm.nih.gov/pubmed/19720998?dopt=Abstract]
[biblio_custom2] => [DK063608]
[biblio_custom3] => [19720998]
[biblio_custom4] => []
[biblio_custom5] => []
[biblio_custom6] => []
[biblio_custom7] => []
[biblio_auth_address] => []
[biblio_remote_db_name] => []
[biblio_remote_db_provider] => []
[biblio_citekey] => [19720998]
[biblio_label] => []
[biblio_access_date] => []
[biblio_type_name] => [Journal Article]
[path] => [biblio/generation-pluripotent-stem-cells-patients-with-type-1-diabetes]
[nodewords] => []
[last_comment_timestamp] => [1254329253]
[last_comment_name] => []
[comment_count] => [0]
[taxonomy] => array (
[89] => stdClass (
[0] => [**Recursion Detected**]
)
[2296] => stdClass (
[0] => [**Recursion Detected**]
)
)
[files] => []
[page_title] => []
[content] => array (
[body] => array (
[#value] => [<span class="Z3988" title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rfr_id=info%3Asid%2Fwww.diabetescenters.org&rft.genre=article&rft.atitle=Generation+of+pluripotent+stem+cells+from+patients+with+type+1+diabetes.&rft.title=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&rft.date=2009&rft.aulast=Maehr+R&rft.aufirst=Chen+Snitow+Ludwig+Yagasaki+Goland+Leibel+RL+Melton+DA&rft_id=http%3A%2F%2Fwww.pnas.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D19720998"></span><div class="biblio_type"><h3>Publication Type:</h3> Journal Article</div>
<div class="biblio_authors"><h3>Authors:</h3> <a href="/biblio/author/Maehr+R">Maehr R , Chen S , Snitow M , Ludwig T , Yagasaki L , Goland R , Leibel RL , Melton DA ,</a></div>
<div class="biblio_source"><h3>Source: </h3> Proceedings of the National Academy of Sciences of the United States of America (2009)</div>
<h3>URL:</h3><a href="http://www.pnas.org/cgi/pmidlookup?view=long&pmid=19720998">http://www.pnas.org/cgi/pmidlookup?view=long&pmid=19720998</a>
<h3>Abstract:</h3> <p>Type 1 diabetes (T1D) is the result of an autoimmune destruction of pancreatic beta cells. The cellular and molecular defects that cause the disease remain unknown. Pluripotent cells generated from patients with T1D would be useful for disease modeling. We show here that induced pluripotent stem (iPS) cells can be generated from patients with T1D by reprogramming their adult fibroblasts with three transcription factors (OCT4, SOX2, KLF4). T1D-specific iPS cells, termed DiPS cells, have the hallmarks of pluripotency and can be differentiated into insulin-producing cells. These results are a step toward using DiPS cells in T1D disease modeling, as well as for cell replacement therapy.</p>
]
[#printed] => [1]
)
[#children] => [<span class="Z3988" title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rfr_id=info%3Asid%2Fwww.diabetescenters.org&rft.genre=article&rft.atitle=Generation+of+pluripotent+stem+cells+from+patients+with+type+1+diabetes.&rft.title=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&rft.date=2009&rft.aulast=Maehr+R&rft.aufirst=Chen+Snitow+Ludwig+Yagasaki+Goland+Leibel+RL+Melton+DA&rft_id=http%3A%2F%2Fwww.pnas.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D19720998"></span><div class="biblio_type"><h3>Publication Type:</h3> Journal Article</div>
<div class="biblio_authors"><h3>Authors:</h3> <a href="/biblio/author/Maehr+R">Maehr R , Chen S , Snitow M , Ludwig T , Yagasaki L , Goland R , Leibel RL , Melton DA ,</a></div>
<div class="biblio_source"><h3>Source: </h3> Proceedings of the National Academy of Sciences of the United States of America (2009)</div>
<h3>URL:</h3><a href="http://www.pnas.org/cgi/pmidlookup?view=long&pmid=19720998">http://www.pnas.org/cgi/pmidlookup?view=long&pmid=19720998</a>
<h3>Abstract:</h3> <p>Type 1 diabetes (T1D) is the result of an autoimmune destruction of pancreatic beta cells. The cellular and molecular defects that cause the disease remain unknown. Pluripotent cells generated from patients with T1D would be useful for disease modeling. We show here that induced pluripotent stem (iPS) cells can be generated from patients with T1D by reprogramming their adult fibroblasts with three transcription factors (OCT4, SOX2, KLF4). T1D-specific iPS cells, termed DiPS cells, have the hallmarks of pluripotency and can be differentiated into insulin-producing cells. These results are a step toward using DiPS cells in T1D disease modeling, as well as for cell replacement therapy.</p>
]
[#printed] => [1]
)
[links] => array (
[comment_forbidden] => array (
[title] => [<a href="/user/login?destination=comment/reply/22980%2523comment-form">Login</a> to post comments]
[html] => [1]
)
)
);
